Author | David O'Malley, MD | OncLive

Author | David O'Malley, MD

Articles

Dr. O’Malley on the Utility of Mirvetuximab in Ovarian Cancer

June 24, 2020

Video

David O'Malley, MD, discusses the utility of mirvetuximab soravtansine in ovarian cancer.

Dr. O'Malley on Antitumor Activity With Veliparib Combo in Serous Ovarian Cancer

April 22, 2020

Video

David O'Malley, MD, discusses antitumor activity with veliparib in combination with chemotherapy in patients with high grade serous ovarian cancer.

Dr. O'Malley on Increased Benefit of Rucaparib Maintenance in RAD51C/D-Mutant Ovarian Cancer

April 10, 2020

Video

David O'Malley, MD, discusses the increased benefit of rucaparib maintenance in patients with ovarian cancer who express RAD51C/D mutations.

Dr. O'Malley on Maintenance Rucaparib in Non-BRCA HRR-Mutated Ovarian Cancer

April 09, 2020

Video

David O’Malley, MD, discusses the rationale to evaluate the clinical benefit of rucaparib maintenance treatment following disease progression in a subgroup of patients with ovarian cancer whose disease is associated with a mutation in a non-BRCA homologous recombination gene in the phase III ARIEL3 trial in ovarian cancer.

x